Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
$
30.00
Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
Lieuwe de Haan, MD, PhD, Britt Hoogeboom, MD, Nico Beuk, MD, Luuk Wouters, Peter M.A.J. Dingemans, PhD, and Don H. Linszen, MD, PhD
Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 39 No. 1 Articles
Tags:
assessment
,
britt-hoogeboom
,
co-morbidity
,
don-h-linszen
,
lieuwe-de-haan
,
luuk-wouters
,
nico-beuk
,
obsessive-compulsive-disorder
,
peter-m-a-j-dingemans
,
psychometric-evaluation
Description
Description
ORIGINAL RESEARCH
Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
Lieuwe de Haan, MD, PhD, Britt Hoogeboom, MD, Nico Beuk, MD, Luuk Wouters, Peter M.A.J. Dingemans, PhD, and Don H. Linszen, MD, PhD
025-030_PB_V39N1_de_Haan
Share On Facebook
Tweet This Product
Pin This Product
Email This Product
Related products
Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder
$
30.00
Add to cart
Details
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
$
30.00
Add to cart
Details
Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
$
0.00
Add to cart
Details
Arif Khan, MD: Suicide Risk Analysis Among Patients Assigned to Psychotropics and Placebo
$
30.00
Add to cart
Details
Close product quick view
×
Title
Page load link
Go to Top